SJFT Performance, Inhibitory Control, and Attention in Young Judokas
The Relationship Between Special Judo Fitness Test (SJFT) Performance and Inhibitory Control and Selective Attention in Young Judokas
This study will examine the relationship between judo-specific physical fitness and cognitive performance in young male judo athletes and will evaluate the immediate effects of the Special Judo Fitness Test (SJFT) on attention and inhibitory control. Licensed male judo athletes who train regularly at least three days per week will be compared with male participants who do not actively participate in sports.
Judo athletes will complete a standardized warm-up followed by the SJFT, a judo-specific high-intensity fitness test involving repeated throws performed over three short exercise periods separated by brief rest intervals. Heart rate will be measured immediately after the SJFT and again one minute later.
Cognitive performance will be assessed using a computerized Flanker Task, which will measure reaction time and response accuracy while participants respond to relevant visual information and ignore distracting information. Judo athletes will complete the Flanker Task approximately one minute before and one minute after the SJFT. Participants in the control group will complete the same cognitive assessment twice over a similar time interval without performing the physical exercise.
The study will aim to determine whether judo-specific physical fitness and judo experience are associated with attention and inhibitory control and whether a single high-intensity judo-specific exercise session will produce an immediate change in cognitive performance.
Descripción general del estudio
Estado
Intervención / Tratamiento
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Türkiye
-
Istanbul, Türkiye, Turquía (Türkiye), 34342
- Boğaziçi University
-
Contacto:
- Muhammed Sıddık Çemç, Dr.
- Número de teléfono: +90 537 016 29 25
- Correo electrónico: mscemc@gmail.com
-
Contacto:
- Correo electrónico: mscemc@gmail.com
-
Investigador principal:
- Muhammed Sıddık Çemç, Dr.
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
Acepta Voluntarios Saludables
Descripción
Inclusion Criteria:
Male participants residing in Istanbul. For the judo group: licensed judo athletes who regularly participate in judo training at least three days per week.
For the control group: individuals who are not actively involved in any sports branch.
Right-handed participants, as determined using the Edinburgh Handedness Inventory.
Participants who provide informed consent to participate in the study.
Exclusion Criteria:
History of visual impairment. History of neurological disorders. History of psychiatric disorders. History of cardiovascular disease. Current medication use.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Otro
- Asignación: No aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Judo Group
Participants in the judo group will complete a standardized warm-up followed by the Special Judo Fitness Test (SJFT).
Cognitive performance will be assessed using the Flanker Task approximately one minute before and one minute after the SJFT.
|
The Special Judo Fitness Test is a judo-specific high-intensity exercise test consisting of three exercise periods: 15 seconds, 30 seconds, and 30 seconds, with 10-second rest intervals between periods.
During the test, the participant will perform as many ippon-seoi-nage throws as possible using two partners positioned six meters apart.
|
|
Sin intervención: Control Group
Participants in the control group will not perform the SJFT or any other exercise intervention.
They will complete the Flanker Task twice over a similar time interval while remaining at rest.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in Flanker Task Correct Responses
Periodo de tiempo: Approximately 1 minute before and 1 minute after the intervention
|
Response accuracy will be assessed using a computerized Flanker Task.
The number of correct responses will be recorded separately for congruent and incongruent trials.
Higher numbers of correct responses indicate greater response accuracy.
|
Approximately 1 minute before and 1 minute after the intervention
|
|
Change in Flanker Task Reaction Time
Periodo de tiempo: Approximately 1 minute before and 1 minute after the intervention
|
Reaction time will be assessed for congruent and incongruent trials using a computerized Flanker Task.
Lower reaction times indicate faster cognitive responses.
|
Approximately 1 minute before and 1 minute after the intervention
|
Colaboradores e Investigadores
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Estimado)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Otros números de identificación del estudio
- E-84391427-050.04-297820
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .